Ethris vs SonoThera

Ethris logo

Ethris

Clinical stage biotech company focused on development of disruptive mRNA therapeutics for severe respiratory diseases

34 employees · est. 2009 · Planegg, Germany

VS
SonoThera logo

SonoThera

SonoThera is developing ultrasound-mediated nonviral genetic therapies

54 employees · est. 2021 · South San Francisco, United...

Ethris is the older company (2009 vs 2021); SonoThera is the larger of the two.

Side-by-Side Comparison

Ethris SonoThera
Founded
2009 older 2021
Headquarters
Planegg, Germany South San Francisco, United States
Employees
34 54 larger
Industry
Biopharma, Biotechnology, Pharmaceutical Biopharma, Biotechnology
Funding Stage
Venture round Series A
Total Funding
$84.80M $60.75M
Funding Rounds
8 1
Services
Development of mRNA therapeutics, Innovative RNA delivery platforms, Collaborative partnerships and licensing, Clinical pipeline advancement Development of Ultrasound-Mediated Gene Delivery Technology, Nonviral Genetic Medicine for Targeted Delivery, Research and Development in Genetic Medicine
Target Customers
Pharmaceutical companies, Biotech firms, Healthcare providers, Patients with respiratory and genetic disorders Patients with Genetic Disorders, Pharmaceutical Companies, Biotech Research Institutions, Healthcare Providers
Taxonomy
Messenger RNA TechnologyTherapeutic ProteinsTranscript TherapiesIntegrated PlatformGene TherapyDrug Development +3 Ultrasound-mediated TherapiesNonviral Genetic TherapiesGenetic MedicineDisease Treatment InnovationGene TherapyUltrasound Technology +5
Website
ethris.com sonothera.com
Ethris logo

About Ethris

Ethris, founded in 2009 and headquartered in Germany, is a pioneering player in the Biopharma, Biotechnology, and Pharmaceutical industries, notably also making strides in Clean Energy. The company is distinguished by its innovative approach to using its proprietary messenger RNA technology platform...

SonoThera logo

About SonoThera

SonoThera is a promising player in the Biopharma and Biotechnology industries, founded in 2021 and headquartered in the United States. The company is carving a niche by developing ultrasound-mediated nonviral genetic therapies, a cutting-edge technological approach that sets it apart in the competit...

Also comparing in this category

Comparing more than these two?

Get Ethris, SonoThera and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Ethris compare?

A PDF of Ethris and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

Ethris was founded in 2009, based in Planegg, Germany, with 34 employees. Ethris, founded in 2009 and headquartered in Germany, is a pioneering player in the Biopharma, Biotechnology, and Pharmaceutical industries, notably also making strides in Clean Energy. The company is. SonoThera was founded in 2021, based in South San Francisco, United States, with 54 employees. SonoThera is a promising player in the Biopharma and Biotechnology industries, founded in 2021 and headquartered in the United States. The company is carving a niche by developing ultrasound-mediated.
Ethris has raised $84.80M and SonoThera $60.75M. Latest stage: Ethris Venture round, SonoThera Series A.
Both work in Biopharma and Biotechnology and list gene therapy among their focus areas.

Compare Ethris with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Ethris on 11 Sep 2024, and SonoThera on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes